Risk Factors for Coronary Artery Disease and Atherothrombotic Brain Infarction in the Elderly

  • Wilbert S. Aronow
Part of the Contemporary Geriatric Medicine book series (COGM, volume 3)


Risk factors that predispose to the pathogenesis of coronary artery disease (CAD) in young and middle-aged persons include cigarette smoking,1–13hypercholesterolemia,4,14–23 systolic and diastolic hypertension,24–32 diabetes mellitus,17,33–40 obesity,41,–42 and physical inactivity.9,43–46 Cigarette smoking, systolic and diastolic hypertension, and hypercholesterolemia are the three major risk factors contributing to the development of CAD in young and middle-aged persons. Systolic and diastolic hypertension and diabetes mellitus are the major risk factors predisposing to the pathogenesis of atherothrombotic brain infarction(ABI).31,47–51 The relationship of cigarette smoking,47–50,52 serum total cholesterol,47–49,53,54 and obesity47–51 to ABI is unclear. This chapter will discuss risk factors predisposing to the pathogenesis of CAD and of ABI in the elderly person.


Coronary Heart Disease Cigarette Smoking Angina Pectoris Systolic Hypertension Framingham Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hammond, E. C., 1964, Smoking in relation to mortality and morbidity. Findings in first thirty-four months of follow-up in prospective study started in 1959, J. Natl Cancer Inst. 32:1161–1188.PubMedGoogle Scholar
  2. 2.
    Doyle, J. T., Dawber, T. R., Kannel, W. B., et al, 1964, The relationship of cigarette smoking to coronary heart disease: the second report of the combined experience of Albany, NY, and Framingham, Mass. studies, JAMA 190:886–890.PubMedGoogle Scholar
  3. 3.
    Doll, R. and Peto, R., 1976, Mortality in relation to smoking: 20 years’ observations on male British doctors, Br. Med. J. 2:1525—1536.PubMedGoogle Scholar
  4. 4.
    Pooling Project Research Group, 1978, Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and EGG abnormalities to incidence of major coronary events: fmal report of the Pooling Project, J. Chronic Dis. 31:201–306.Google Scholar
  5. 5.
    Friedman, G. D., Dales, L. G., and Ury, H. K., 1979, Mortality in middle- aged smokers and nonsmokers, N. Engl. J. Med. 300:213—217.PubMedGoogle Scholar
  6. 6.
    Doll, R., Gray, R., Hafner, B., and Peto, R., 1980, Mortality in relation to smoking: 22 years’ observations on female British doctors, Br. Med. J. 1:967–971.Google Scholar
  7. 7.
    Jenkins, G. D., Rosenman, R. H., and Zyzanski, S. J., 1968, Gigarette smoking: its relationship to coronary heart disease and related risk factors in the Western collaborative group study. Circulation 38:1140–1155.PubMedGoogle Scholar
  8. 8.
    Stamler, J., Berkson, D. M., Levinson, M., et al., 1966, Goronary heart disease. Status of preventive efforts. Arch. Environ. Health 13:322—335.PubMedGoogle Scholar
  9. 9.
    Shapiro, S., Weinblatt, E., Frank, G. W., and Sager, R. V., 1969, Incidence of coronary heart disease in a population insured for medical care (HIP): myocardial infarction, angina pectoris, and possible myocardial infarction. Am. J. Puhl. Health 59(Suppl): 1–101.Google Scholar
  10. 10.
    Stone, D., Shapiro, S., Rosenberg, L., et al, 1978, Relation of cigarette smoking to myocardial infarction in young women, N. Engl. J. Med. 298:1273–1276.Google Scholar
  11. 11.
    Spain, D. M. and Bradess, V. A., 1970, Sudden death from coronary heart disease. Survival time, frequency of thrombi, and cigarette smoking. Chest 58:107–110.PubMedGoogle Scholar
  12. 12.
    Spain, D. M., Siegel, H., and Bradess, V. A., 1973, Women smokers and sudden death. The relationship of cigarette smoking to coronary disease, JAMA 224:1005–1007.PubMedGoogle Scholar
  13. 13.
    Doyle, J. T., Kannel, W. B., McNamara, P. M., et. al., 1976, Factors related to suddenness of death from coronary disease: Gombined Albany—Framingham studies. Am. J. Cardiol. 37:1073–1078.PubMedGoogle Scholar
  14. 14.
    Robertson, T. L., Kato, H., Gordon, T., et al., 1977, Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and Galifornia: coronary heart disease risk factors in Japan and Hawaii, Am. J. Cardiol 39:244–249.PubMedGoogle Scholar
  15. 15.
    Keys, A. (ed. ), 1970, Goronary heart disease in seven countries. Circulation 41(Suppl 1):1–211.Google Scholar
  16. 16.
    Waiden, R. T., Schaefer, L. A., Lemon, F. R., et al, 1964, Effect of environment on the serum cholesterol-triglyceride distribution among Seventh- day Adventists, Am. J. Med. 36:269–276.Google Scholar
  17. 17.
    Aronow, W. S., Uyeyama, R. R., and Cassidy, J., 1973, Serum lipids, serum uric acid and glucose tolerance in coronary heart disease, J. Am. Geriatr. Soc. 21:58–62.PubMedGoogle Scholar
  18. 18.
    Gotto, A. M., Gorry, G. A., Thompson, J. R., et. al., 1977, Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 56:875—883.PubMedGoogle Scholar
  19. 19.
    Kannel, W. B., Castelli, W. P., and Gordon, T., 1979, Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Fra- mingham Study, Ann. Intern. Med. 90:85–91.PubMedGoogle Scholar
  20. 20.
    Vlietstra, R. E., Frye, R. L., Kronmal, R. A., et al, 1980, Risk factors and angiographic coronary artery disease: A report from the Coronary Artery Surgery Study (CASS), Circulation 62:254–261.PubMedGoogle Scholar
  21. 21.
    Hjermann, I., Velve-Byre, K., Holme, I., and Leren, P., 1981, Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in healthy men. Lancet 2:1303–1310.PubMedGoogle Scholar
  22. 22.
    22. The Lipid Research Clinics Coronary Primary Prevention Trial Results, 1984, I. Reduction in incidence of coronary heart disease: Lipid Research Clinics Program, JAMA 251:351–364.Google Scholar
  23. 23.
    23. The Lipid Research Clinics Coronary Primary Prevention Trial Results, 1984, II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA 251:365–374.Google Scholar
  24. 24.
    Kannel, W. B., Dawber, T. R., and McGee, D. L., 1980, Perspectives on systolic hypertension. The Framingham Study, Circulation 61:1179—1182.PubMedGoogle Scholar
  25. 25.
    Kannel, W. B., Sorlie, P., and Gordon, T., 1980, Labile hypertension: A faulty concept? The Framingham Study, Circulation 61:1183–1187.PubMedGoogle Scholar
  26. 26.
    Morton, P. A., 1959, Ordinary insurance: the build and blood pressure study. Trans. Soc. Actuar. 11:987–997.Google Scholar
  27. 27.
    Rabkin, W. S., Mathewson, F. A. L., and Tate, R. B., 1978, Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures, Ann. Intern. Med. 88:342—345.PubMedGoogle Scholar
  28. 28.
    Shea, S., Cook, E. F., Kannel, W. B., and Goldman, L., 1985, Treatment of hypertension and its effect on cardiovascular risk factors: Data from the Framingham Heart Study, Circulation 71:22–30.PubMedGoogle Scholar
  29. 29.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1967, Effects of treatment on morbidity in hypertension. 1. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg, JAMA 202:1028–1034.Google Scholar
  30. 30.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1970, Effects of treatment on morbidity in hypertension. IL Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg, JAMA 213:1143–1152.Google Scholar
  31. 31.
    Hypertension Detection and Follow-up Program Cooperative Group, 1979, Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension, JAMA 242:2562–2571.Google Scholar
  32. 32.
    Report by the Management Committee, 1980, The Australian therapeutic trial in mild hypertension, Lancet 1:1261–1267.Google Scholar
  33. 33.
    Aronow, W. S., Suryanarayana, B. V., and Kent, J. R., 1971, Myocardial infarction and carbohydrate metabolism relating to diabetes mellitus, California Med, 115:16–20.PubMedGoogle Scholar
  34. 34.
    Heinle, R. A., Levy, R. I., Fredrickson, D. S., and Gorlin, R., 1969, Lipid carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am. J. Cardiol. 24:178—186.PubMedGoogle Scholar
  35. 35.
    Falsetti, H. L., Schnatz, J. D., Greene, D. G., and Bunnell, I. L., 1970, Serum lipids and glucose tolerance in angiographically proved coronary artery disease. Chest 58:111–115.PubMedGoogle Scholar
  36. 36.
    Bryfogle, J. W., and Bradley, R. F., 1957, The vascular complications of diabetes mellitus: A clinical study. Diabetes 6:159—167.PubMedGoogle Scholar
  37. 37.
    Ostrander, L. D., Jr., Frances, T., Jr., Hayner, N. S., et al, 1965, The relationship of cardiovascular disease to hyperglycemia, Ann. Intern. Med. 62:1188–1198.PubMedGoogle Scholar
  38. 38.
    Garcia, M. J., McNamara, P. M., Gordon, T., and Kannel, W. B., 1976, Morbidity and mortality of diabetes in the Framingham population. 16 year follow-up. Diabetes 23:105–111.Google Scholar
  39. 39.
    Kannel, W. B. and McGee, D. L., 1979, Diabetes and cardiovascular disease: the Framingham study, JAMA 241:2035–2038.PubMedGoogle Scholar
  40. 40.
    Kannel, W. B., McNamara, P. M., Feinleib, M., and Dawber, T. R., 1970, The unrecognized myocardial infarction: 14 year follow-up experience in the Framingham study. Geriatrics 25:75—87.PubMedGoogle Scholar
  41. 41.
    Rabkin, S. W., Mathewson, F. A. L., and Hsu, P. H., 1977, Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26-year observation period: The Manitoba study. Am. J. Cardiol. 39:452–458.PubMedGoogle Scholar
  42. 42.
    Hubert, H. B., Feinleib, M., McNamara, P. M., and Gastelli, W. P., 1983, Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study, Circulation 67:968–977.PubMedGoogle Scholar
  43. 43.
    Paffenbarger, R. S., and Hale, W. E., 1975, Work activity and coronary heart mortality, N. Engl. J. Med. 292:545–550.PubMedGoogle Scholar
  44. 44.
    Kannel, W. B., and Sorlie, P., 1979, Some health benefits of physical activity: the Framingham study. Arch. Intern. Med. 139:857—861.PubMedGoogle Scholar
  45. 45.
    Paffenbarger, R. S., Hyde, R. T., Wing, A. L., and Hsieh, G-G, 1984, A natural history of athleticism and cardiovascular health, JAMA 252:491–495.Google Scholar
  46. 46.
    Garcia-Palmieri, M. R., Gostas, R., Jr., Gruz-Vidal, M., et al, 1982, Increased physical activity: a protective factor against heart attacks in Puerto Rico, Am. J. Cardiol. 50:749–755.PubMedGoogle Scholar
  47. 47.
    Wolf, P. A. and Kannel, W. B., 1981, Gontrollable risk factors for stroke: Preventive implications of trends in stroke mortality, in: Diagnosis and Management of Stroke and TIA’s (J. S. Meyer, and T. Shaw, eds. ), Addison- Wesley, Reading, MA, pp. 25–61.Google Scholar
  48. 48.
    Takeya, Y., Popper, J. S., Shimizu, Y., et al., 1984, Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Incidence of stroke in Japan and Hawaii, Stroke 15:15–23.PubMedGoogle Scholar
  49. 49.
    Dyken, M. L., Wolf, P. A., Barnett, H. J. M., et al, 1984, Risk factors in stroke. A statement for physicians by the Subcommittee on Risk Factors and Stroke of the Stroke Council, Stroke 15:1105—1111.Google Scholar
  50. 50.
    Paffenbarger, R. S., Jr. and Williams, J. L., 1967, Chronic disease in former college students. V. Early precursors of fatal stroke. Am. J. Public Health 57:1290–1299.Google Scholar
  51. 51.
    Chapman, J. M., Reeder, L. G., Borun, E. R., et al, 1966, Epidemiology of vascular lesions affecting the central nervous system: the occurrence of strokes in a sample population under observation for cardiovascular disease, Am. J. Public Health 56:191–201.Google Scholar
  52. 52.
    Hammond, E. C., 1964, Smoking in relation to death rates of one million men and women, Natl. Cancer Inst. Monogr. 19:127—204.Google Scholar
  53. 53.
    Dyer, A. R., Stamler, J., Paul, O., et al., 1981, Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies, J. Chronic Dis. 34: 249–260.PubMedGoogle Scholar
  54. 54.
    Mathew, N. T., Davis, D., Meyer, J. S., and Chander, K., 1975, Hyperlipoproteinemia in occlusive cerebrovascular disease, JAMA 232:262—266.PubMedGoogle Scholar
  55. 55.
    Aberg, A., Bergstrand, R., Johansson, S., et al., 1983, Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br. Heart J. 44:416–422.Google Scholar
  56. 56.
    Hammond, E. C. and Garfmkel, L., 1969, Coronary heart disease, stroke, and aortic aneurysm. Factors in the etiology, Arch. Environ. Health 19:167—182.Google Scholar
  57. 57.
    Auerbach, O., Carter, H. W., Garfmkel, L., and Hammond, E. C., 1976, Cigarette smoking and coronary artery disease: a macroscopic and microscopic study, Chest 70:697–705.PubMedGoogle Scholar
  58. 58.
    Strong, J. P. and Richards, M. L., 1976, Cigarette smoking and atherosclerosis in autopsied men, Atherosclerosis 23:451–476.PubMedGoogle Scholar
  59. 59.
    McMillan, G. C. and Aronow, W. S., 1976, Recommendations: subsection B: relation of smoke components to cardiovascular disease, in: Smoking and Health. I. Modifying the Risk for the Smoker. Proceedings Third World Conference on Smoking and Health (E. L. Wynder, D. Hoffman, and G. B. Gori, eds. ). Government Printing Office, Washington, DC, pp. 548—549.Google Scholar
  60. 60.
    Kannel, W. B., 1981, Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101:319–328.PubMedGoogle Scholar
  61. 61.
    Aronow, W. S., Kaplan, M. A., and Jacob, D., 1968, Tobacco: a precipitating factor in angina pectoris, Ann. Intern. Med. 69:529—536.PubMedGoogle Scholar
  62. 62.
    Aronow, W. S. and Swanson, A. J., 1969, The effect of low-nicotine cigarettes on angina pectoris, Ann. Intern. Med. 71:599–601.PubMedGoogle Scholar
  63. 63.
    Aronow, W. S. and Rokaw, S. N., 1971, Carboxyhemoglobin caused by smoking non-nicotine cigarettes: effects on angina pectoris. Circulation 44:782–788.PubMedGoogle Scholar
  64. 64.
    Aronow, W. S. and Cassidy, J., 1975, Effect of smoking marihuana versus a high-nicotine cigarette on angina pectoris, Clin. Pharmacol. Ther. 17:549—554.PubMedGoogle Scholar
  65. 65.
    Aronow, W. S., 1980, Effect of non-nicotine cigarettes and carbon monoxide on angina. Circulation 61:262—265.PubMedGoogle Scholar
  66. 66.
    Aronow, W. S., Dendinger, J., and Rokaw, S. N., 1971, Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes: A study in male patients with angina pectoris, Ann. Intern. Med. 74:697–702.PubMedGoogle Scholar
  67. 67.
    Aronow, W. S., Goldsmith, J. R., Kern, J. C., et al, 1974, Effect of smoking cigarettes on cardiovascular hemodynamics, Arch. Environ. Health 28:330–332.PubMedGoogle Scholar
  68. 68.
    Aronow, W. S., Cassidy, J., Vangrow, J. S., et al, 1974, Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation 50:340–347.PubMedGoogle Scholar
  69. 69.
    Aronow, W. S., Harris, C. N., Isbell, M. W., et al, 1972, Effect of freeway travel on angina pectoris, Ann. Intern. Med. 77:669—676.PubMedGoogle Scholar
  70. 70.
    Aronow, W. S. and Isbell, M. W., 1973, Carbon monoxide effect on exercise-induced angina pectoris, Ann. Intern. Med. 79:392–395.PubMedGoogle Scholar
  71. 71.
    Aronow, W. S., 1981, Aggravation of angina pectoris by two percent car- boxyhemoglobin. Am. Heart J. 101:154—157.PubMedGoogle Scholar
  72. 72.
    Levine, P. H., 1973, An acute effect of cigarette smoking on platelet function: A possible link between smoking and arterial thrombosis. Circulation 48:619–623.PubMedGoogle Scholar
  73. 73.
    Bellet, S., Deguzman, N. T., Kostis, J. B., et al, 1972, The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and in dogs with acute myocardial infarction. Am. Heart J. 83:67–76.PubMedGoogle Scholar
  74. 74.
    DeBias, D. A., Banerjee, C. M., Birkhead, N. C., et al, 1973, Carbon monoxide inhalation effects following myocardial infarction in monkeys. Arch. Environ. Health 27:161–167.PubMedGoogle Scholar
  75. 75.
    Birnstingl, M. A., Brinson, K., and Chakrabarti, B. K., 1971, The effect of short-term exposure to carbon monoxide on platelet stickiness, Br. J. Surg. 58:837–839.PubMedGoogle Scholar
  76. 76.
    DeBias, D. A., Banerjee, C. M., Birkhead N. C., et al, 1976, Effects of carbon monoxide inhalation on ventricular fibrillation, Arch. Environ. Health 31:38–42.Google Scholar
  77. 77.
    Aronow, W. S., Stemmer, E. A., Wood, B., et al, 1978, Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial injury. Am. Heart J. 95:754–756.PubMedGoogle Scholar
  78. 78.
    Castelli, W. P., Dawber, T. R., Feinleib, M., et al, 1981, The filter cigarette and coronary heart disease. The Framingham sudy. Lancet 2:109–113.PubMedGoogle Scholar
  79. 79.
    Kaufman, D. W., Helmrich, S. P., Rosenberg, L., et al, 1983, Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men, N. Engl J. Med. 308: 409–413.PubMedGoogle Scholar
  80. 80.
    Jajich, C. L., Ostfeld, A. M., and Freeman, D. H., Jr., 1984, Smoking and coronary heart disease mortality in the elderly, JAMA 252:2831–2834.PubMedGoogle Scholar
  81. 81.
    Kannel, W. B., and Brand, F. N., 1985, Cardiovascular risk factors in the elderly, in: Principles of Geriatric Medicine (R. Andres, E. L. Bierman, and W. R. Hazzard, eds. ), McGraw-Hill, New York, pp. 104–119.Google Scholar
  82. 82.
    Aronow, W. S., Starling, L., Etienne, F., et al, 1986, Risk factors for coronary artery disease in persons older than 62 years in a long-term health care facility. Am. J. Cardiol 57:518–520.PubMedGoogle Scholar
  83. 82a.
    Aronow, W. S., Etienne, F., D’Alba, P., and Ronquillo, J., 1988, Risk factors correlated with new coronary events in elderly persons, Clin. Res, 36:2A.Google Scholar
  84. 83.
    Grundy, S. M., 1984, Hyperlipoproteinemia: metabolic basis and rationale for therapy, Am. J. Cardiol. 54:20C-26C.PubMedGoogle Scholar
  85. 84.
    Castelli, W. P., Doyle, J. T., Gordon, T., et al, 1977, HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phe- notyping Study, Circulation 55:767–772.PubMedGoogle Scholar
  86. 85.
    Miller, N. E., Thelle, D. S., F0rde, O. H., and Mj0s, O. D., 1977, The Troms0 heart-study. High density lipoprotein and coronary heart-disease: A prospective case-study, Lancet 1:965—967.PubMedGoogle Scholar
  87. 86.
    Kannel, W. B., 1983, High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am. J. Cardiol. 52:9B-12B.PubMedGoogle Scholar
  88. 87.
    Goldstein, J. L., Hazzard, W. R., Schrott, H. G., et al, 1973, Hyper- lipidemia in coronary heart disease: I. Lipid levels in 500 survivors of myocardial infarction, J. Clin. Invest. 52:1533—1543.PubMedGoogle Scholar
  89. 88.
    Carlson, L. A., Böttiger, L. E., and Ähfeldt, P. E., 1979, Risk factors for myocardial infarction in the Stockholm prospective study: A 14-year fol- low-up focusing on the role of plasma triglycerides and cholesterol, Acta Med. Scand. 206:351–360.PubMedGoogle Scholar
  90. 89.
    Hulley, S. B., Rosenman, R. H., Bawol, R. D., and Brand, R. J., 1980, Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease, N. Engl. J. Med. 302:1383–1389.PubMedGoogle Scholar
  91. 90.
    Consensus Conference, 1984, Treatment of hypertriglyceridemia, JAMA 251:1196–1200.Google Scholar
  92. 91.
    Dayton, S., Pearce, M. L., Hashimoto, S., et al., 1969, A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis, Circulation 40(Suppl II): 1–63.Google Scholar
  93. 92.
    Turpeinen, O., Karvonen, M. J., Pekkarinen, M., et al, 1979, Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study, Int. J. Epidemiol. 8:99–118.PubMedGoogle Scholar
  94. 93.
    Multiple Risk Factor Intervention Trial Research Group, 1983, Multiple risk factor intervention trial: Risk factor changes and mortality results, JAMA 248:1465–1477.Google Scholar
  95. 94.
    Kushi, L. H., Lew, R. A., Stare, F. J., et al, 1985, Diet and 20-year mortality from coronary heart disease: The Ireland-Boston Diet-Heart Study, N. Engl. J. Med. 312:811–818.PubMedGoogle Scholar
  96. 96.
    95. The Coronary Drug Project Research Group, 1975, Clofibrate and niacin in coronary heart disease, JAMA 231:360–381.Google Scholar
  97. 96.
    Canner, P. L., Berge, K. G., Wenger, N. K., et al., 1986, Fifteen year mortality in coronary drug project patients: long term benefit with niacin, J. Am. Coll. Cardiol. 8:1245–1255.PubMedGoogle Scholar
  98. 97.
    Brensike, J. F., Levy, R. L., Kelsey, S. F., et al., 1984, Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II Coronary Intervention Study, Circulation 69:313–324.PubMedGoogle Scholar
  99. 98.
    Levy, R. L, Brensike, J. F., Epstein, S. E., et al, 1984, The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI type II Coronary Intervention Study, Circulation 69:325–337.PubMedGoogle Scholar
  100. 99.
    Arntzenius, A. C., Kromhout, D., Barth, J. D., et al, 1985, Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial, N. Engl]. Med. 312:805–811.Google Scholar
  101. 100.
    Consensus Conference, 1985, Lowering blood cholesterol to prevent heart disease, JAMA 253:2080–2086.Google Scholar
  102. 101.
    Dyer, A. R., Stamler, J., Shekelle, R. B., et al, 1977, Hypertension in the elderly, Med. Clin. North Am. 61:513–529.PubMedGoogle Scholar
  103. 103.
    102. The Working Group on Hypertension in the Elderly, 1986, Statement on hypertension in the elderly, JAMA 256:70–74.Google Scholar
  104. 103..
    The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, 1984, Arch. Intern. Med. 144:1045–1057.Google Scholar
  105. 104.
    National Heart Foundation of Australia Study, 1981, Treatment of mild hypertension in the elderly: Report by the Management Committee, Med. J. Aust. 2:398–402.Google Scholar
  106. 105.
    Amery, A., Birkenhäger, W., Brixko, V., et al, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial, Lancet 1:1349–1354.PubMedGoogle Scholar
  107. 106.
    Aronow, W. S., July, 1985, Coronary risk factors, part 3: Hypertension, Fam. Pract. Recertification 7:53–74.Google Scholar
  108. 107.
    Drayer, J. I. M., Gardin, J. M., Weber, M. A., and Aronow, W. S., 1982, Changes in ventricular septal thickness during diuretic therapy, Clin. Pharmacol. Ther. 32:283–288.PubMedGoogle Scholar
  109. 108.
    Drayer, J. I. M., Gardin, J. M., Weber, M. A., and Aronow, W. S., 1982, Changes in cardiac anatomy and function during therapy with alpha-meth- yldopa: An echocardiographic study, Curr. Ther. Res. 32:856–865.Google Scholar
  110. 109.
    Drayer, J. I. M., Gardin, J. M., Weber, M. A., and Aronow, W. S., 1983, Cardiac muscle mass during vasodilation therapy of hypertension, Clin. Phar. Ther. 33:727–732.Google Scholar
  111. 110.
    Rowe, J. W., 1983, Systolic hypertension in the elderly, N. Engl. J. Med. 309:1246–1247.PubMedGoogle Scholar
  112. 111.
    Hulley, S. B., Furberg, C. D., Gurland, B., et al., 1985, Systolic Hypertension in the Elderly Program (SHEP): Antihypertensive efficacy of chlorthalidone, Am. J. Cardiol. 56:913–920.PubMedGoogle Scholar
  113. 112.
    Hamby, R. I., Zoneraich, S., and Sherman, L., 1974, Diabetic cardiomyopathy, JAMA 229:1749–1754.PubMedGoogle Scholar
  114. 113.
    Kannel, W. B., Hjortland, M., and Castelli, W. P., 1974, Role of diabetes in congestive heart ifailure: The Framingham study. Am. J. Cardiol. 34:29–34.PubMedGoogle Scholar
  115. 114.
    Atherosclerosis Study Group, 1984, Optimal resources for primary prevention of atherosclerotic diseases. Circulation 70:157A—205A.Google Scholar
  116. 115.
    Aronow, W. S., 1985, Coronary risk factors, part 4: Diabetes mellitus, hyperuricemia, obesity, and physical inactivity, Fam. Pract. Recertification 7:69–89.Google Scholar
  117. 116.
    Chiang, B. N., Perlman, L. V., and Epstein, F. H., 1969, Overweight and hypertension. A review. Circulation 39:403—421.PubMedGoogle Scholar
  118. 117.
    Ashley, F. W., and Kannel, W. B., 1974, Relation of weight change to changes in atherogenic traits. The Framingham study., J. Chronic Dis. 27:103–114.PubMedGoogle Scholar
  119. 118.
    Montoye, H. J., Epstein, F. H., and Kjelsberg, M. O., 1966, Relationship between serum cholesterol and body fatness. An epidemiologic study. Am. J. Clin. Nutr. 18:397–406.PubMedGoogle Scholar
  120. 119.
    Krotkiewski, M., Mandroukas, K., Sjostrom, L., et al., 1979, Effects of long- term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 28:650–658.PubMedGoogle Scholar
  121. 120.
    Caggiula, A. W., Christakis, G., Farrand, M., et al, 1981, The multiple risk factor intervention trial (MRFIT). IV. Intervention on blood lipids. Prev. Med. 10:443–475.PubMedGoogle Scholar
  122. 121.
    Huttunen, J. K., Länsimies, E., Voutilainen, E., et al., 1979, Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special references to serum high-density lipoproteins. Circulation 60:1220–1229.PubMedGoogle Scholar
  123. 122.
    Richter, E. A., Ruderman, M. B., and Schneider, S. H., 1981. Diabetes and exercise. Am. J. Med. 70:201–209.PubMedGoogle Scholar
  124. 123.
    Williams, M. A., Maresh, C. M., Aronow, W. S., et al, 1984, The value of early out-patient cardiac exercise programs for the elderly in comparison with other selected age groups, Eur. Heart J. 5(Suppl E):113—115.PubMedGoogle Scholar
  125. 124.
    Naughton, J., 1985, Role of physical activity as a secondary intervention for healed myocardial infarction. Am. J. Cardiol. 55:21D-26D.PubMedGoogle Scholar
  126. 125.
    Gordon, T. G., Kannel, W. B., Hjortland, M. C., and McNamara, P. M., 1978, Menopause and coronary heart disease: The Framingham study, Ann. Intern. Med. 89:157–161.PubMedGoogle Scholar
  127. 126.
    Rogers, R. L., Meyer, J. S., Judd, B. W., and Mortel, K. F., 1985, Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers, JAMA 253:2970–2974.PubMedGoogle Scholar
  128. 127.
    Aronow, W. S., Starling, L., Etienne, F., et al, 1987, Risk factors for athe- rothrombotic brain infarction in persons over 62 years of age in a long- term health care facility, J. Am. Geriatr. Soc. 35:1—3.PubMedGoogle Scholar
  129. 127a.
    Aronow, W. S., Gutstein, H., Lee, N. H., and Edwards, M., 1988, Risk factors correlated with new atherothrombotic brain infraction in elderly persons, Clin. Res. 36:9A.Google Scholar
  130. 128.
    Shekelle, R. B., Ostfeld, A. M., and Klawans, H. L., Jr., 1974, Hypertension and risk of stroke in an elderly population. Stroke 5:71–75.PubMedGoogle Scholar
  131. 129.
    Medical Research Council Working Party, 1985, MRG trial of treatment of mild hypertension: principal results, Br. Med. J. 291:97–104.Google Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Wilbert S. Aronow
    • 1
  1. 1.Hebrew Hospital for Chronic SickBronxUSA

Personalised recommendations